Treating ovarian cancer: New pathways through genetics
A new discovery that sheds light on the genetic make up of ovarian cancer cells could explain why some women survive longer than others with this deadly disease. A multi-disciplinary team led by the Research Institute of ...
Cancer
Sep 24, 2012 |
not rated yet |
0
|
'Fingerprinting' breakthrough offers improved brain tumour diagnosis
(Medical Xpress)—UK scientists have made a breakthrough in a new method of brain tumour diagnosis, offering hope to tens of thousands of people.
Medical research
Sep 21, 2012 |
5 / 5 (2) |
0
|
Gene helps predict which ovarian cancer sufferers will benefit most from chemotherapy
(Medical Xpress)—Researchers from the University of Dundee have discovered that measuring how active a gene is could predict which women with ovarian cancer will benefit from platinum-based chemotherapy ...
Cancer
Sep 19, 2012 |
not rated yet |
0
Human trials have begun on a potentially groundbreaking cancer drug
(Medical Xpress)—In medical science, remarkable things sometimes happen that make years of toiling in the lab worthwhile.
Cancer
Sep 18, 2012 |
5 / 5 (1) |
0
Cloned receptor paves way for new breast and prostate cancer treatment
Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability ...
Cancer
Sep 13, 2012 |
4 / 5 (4) |
0
|
Epigenetics emerges powerfully as a clinical tool
A study coordinated by Manel Esteller, published in Nature Reviews Genetics, highlights the success of this area of research to predict the behavior and weaknesses of tumors.
Genetics
Sep 12, 2012 |
not rated yet |
0
Research shows gaps in unfit driver reporting
(Medical Xpress)—Ontario doctors are legally required to report patients they consider medically unfit to drive to the Ministry of Transportation (MTO) – yet they may not be doing it.
Other
Sep 07, 2012 |
not rated yet |
1
New hope for thousands of women with most aggressive breast cancer
(Medical Xpress)—Scientists at The University of Nottingham have identified a protein which could help predict survival outcomes for women with the most aggressive forms of breast cancer.
Cancer
Sep 07, 2012 |
not rated yet |
0
|
Improving diagnosis of thyroid nodules
Thyroid nodules are thought to be present in about half of all people, but very few of these are cancerous. New research published in BioMed Central's open access journal BMC Cancer presents a set of dia ...
Cancer
Sep 06, 2012 |
not rated yet |
0
Epigenetic causes of prostate cancer
(Medical Xpress)—In about half of all prostate tumours, there are two genetic areas that are fused with one another. When this is not the case, the exact way cancer cells originate in prostate tumours was not clear until ...
Cancer
Sep 05, 2012 |
5 / 5 (2) |
0
Study: Statins may stem tumor growth
(Medical Xpress)—One of the world's top selling drugs potentially also acts against the growth of new lymphatic vessels, with potential implications for cancer therapy. This surprising finding was brought ...
Cancer
Sep 04, 2012 |
5 / 5 (2) |
0
|
Potential drug for treating deadly brain cancer
(Medical Xpress)—A*STAR scientists have identified a biomarker of the most lethal form of brain tumours in adults − glioblastoma multiforme. The scientists found that by targeting this biomarker and depleting ...
Cancer
Sep 04, 2012 |
5 / 5 (2) |
0
|
Diagnosing cancer, pregnancy complications
Based on their previous discovery of progesterone-induced blocking factor (PIBF), European scientists have developed a diagnostic assay that could be used to detect pregnancy complications or cancer.
Medical research
Aug 16, 2012 |
not rated yet |
0
Study suggests patients should be screened before receiving vemurafenib
Different genetic mistakes driving skin cancer may affect how patients respond to the drug vemurafenib, providing grounds to screen people with melanoma skin cancer before treatment, a new study by Cancer Research UK scientists ...
Cancer
Aug 14, 2012 |
not rated yet |
0
|
Benefit of PET and PET/CT in ovarian cancer is not proven
Due to the lack of studies, there is currently no proof that patients with ovarian cancer can benefit from positron emission tomography (PET) alone or in combination with computed tomography (CT). As regards diagnostic accuracy, ...
Cancer
Aug 08, 2012 |
not rated yet |
0
